Please use this identifier to cite or link to this item:
Type: Artigo
Title: Cats (fam64a) Abnormal Expression Reduces Clonogenicity Of Hematopoietic Cells
Author: Barbutti
Isabella; Xavier-Ferrucio
Juliana M.; Machado-Neto
Joao Agostinho; Ricon
Lauremilia; Traina
Fabiola; Bohlander
Stefan K.; Olalla Saad
Sara Teresinha; Archangelo
Leticia Frohlich
Abstract: The CATS (FAM64A) protein interacts with CALM (PICALM) and the leukemic fusion protein CALM/AF10. CATS is highly expressed in leukemia, lymphoma and tumor cell lines and its protein levels strongly correlates with cellular proliferation in both malignant and normal cells. In order to obtain further insight into CATS function we performed an extensive analysis of CATS expression during differentiation of leukemia cell lines. While CATS expression decreased during erythroid, megakaryocytic and monocytic differentiation, a markedly increase was observed in the ATRA induced granulocytic differentiation. Lentivirus mediated silencing of CATS in U937 cell line resulted in somewhat reduced proliferation, altered Cell Cycle progression and lower migratory ability in vitro; however was not sufficient to inhibit tumor growth in xenotransplant model. Of note, CATS knockdown resulted in reduced clonogenicity of CATS-silenced cells and reduced expression of the self-renewal gene, GLI-1. Moreover, retroviral mediated overexpression of the murine Cats in primary bone marrow cells lead to decreased colony formation. Although our in vitro data suggests that CATS play a role in cellular processes important for tumorigenesis, such as Cell Cycle control and clonogenicity, these effects were not observed in vivo.
Subject: Cats (fam64a)
Editor: Impact Journals Llc
Citation: Oncotarget. Impact Journals Llc, v. 7, p. 68385 - 68396, 2016.
Rights: aberto
Identifier DOI: 10.18632/oncotarget.11630
Date Issue: 2016
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
000387446800055.pdf5.28 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.